DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Fizazi K, Scher HI, Molina A. et al.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol 2012;
13: 983-992
DOI: 10.1016/S1470-2045(12)70379-0.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.